Original Article

Hemolytic Crisis in a Patient Treated With Santonin: Possible Santonin Poisoning

Authors: RICHARD R. OLDHAM, BS, Y. M. WANG, BS, JAN VAN EYS, MD, PhD., JAMES P. CARTER, MD, Dr PH

Abstract

Though santonin in the management of ascariasis was discarded several decades ago, it apparently is still available as a proprietary for purchase over the counter. This paper calls attention to its toxicity, a drug which should no longer be purchasable.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References